Lavipharm
Athanasios Antonopoulos, MSc, is a seasoned financial professional with extensive experience in cost control and financial analysis. Currently serving as a Cost Controller at Lavipharm since May 2024, Athanasios is responsible for product costing and the development of cost models. Previously held the role of Financial Planning and Analysis Controller at Landis+Gyr, focusing on budgeting and operational performance analysis, and provided insights for senior management decision-making. Athanasios gained significant experience as a Cost Controller and Financial Business Analyst at EUROCHARTIKI SA, along with a background in purchasing and cost control at DELTA FOODS SA. Athanasios holds a Bachelor's degree in Economics from the University of Macedonia and a Master of Science in Banking and Finance from Elliniko Anoikto Panepistimio.
This person is not in any teams
This person is not in any offices
Lavipharm
1 followers
Lavipharm SA is a Greek commercial and industrial enterprise engaged in the development, manufacture, marketing and distribution of pharmaceutical, cosmetic and over-the-counter (OTC) products. Its main pharmaceutical products cover such categories as anti-inflammatory, asthma controlling, neurological, antiseptic, analgesic, dermatological and gastrointestinal therapies. Its cosmetic products are offered under the brand names of Castalia Soins Dermocosmetiques and Laviderm Active Technology and are used for skin, face and body care, as well as for scalp and hair problems. Its OTC products include cold and flu remedies, oral care, dermatological products, condoms, antiseptics, analgesics, laxatives and gynecology products. It is the parent company of Lavipharm Group of Companies. In January 2014, Robertet SA acquired together with CODIF the HITEX company, specialized in subcontracting of carbon dioxide extraction, from Lavipharm SA.